TrialFrontiers in immunology2025
POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following
Digna T de Bruin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it